Changes in serum CA-125 levels after laparotomy?

There is no adequate data in the medical literature defining serum CA-125 levels after laparotomy. Therefore we designed this prospective study to evaluate the effects of laparotomy for hysterectomy on serum CA-125 levels. Ninety-four women (mean age 44.6 +/- 6.9 years) were included in the study between January, 2001 and April, 2003. Hysterectomies were performed in patients with chronic pelvic pain, dysfunctional uterine bleeding and myoma uteri. Mean serum CA-125 levels of the patients before and after laparotomy were 16.29 +/- 8.11 U/ml and 16.37 +/- 8.05 U/ml, respectively. The change in serum CA-125 levels prior to the operation was statistically insignificant when compared with the levels obtained at 24 hours after laparotomy (p > 0.05). We found that laparotomy for hysterectomy did not change the levels of CA-125 at the 24th hour after the operation, indicating either serum CA-125 levels are not correlated, at least within 24 hours, with peritoneal irritation or peritoneal irritation was minimal or absent in our operations.

Laparotomy; Hysterectomy, CA-125

[1] Kabawat S., Bast R.C., Bhan A.K., Welch W.R., Knapp R.C., Colvin R.B.: "Tissue distribution of a coelomic epithelium-related antigen recognized by monoclonal antibody CA-125". Int. J. Gynecol. Pathol., 1983, 2, 275.

[2] Halila H., Stenman U.H., Seppala M.: "Ovarian cancer antigen CA-125 levels in pelvic inflammatory disease and pregnancy". Cancer, 1986, 57, 1327.

[3] Barbieri R.L., Niloff J.M., Bast R.C. Jr., Schaetzl E., Kistner R.W., Knapp R.C.: "Elevated serum concentrations of CA-125 in patients with advanced endometriosis". Fertil. Steril., 1986, 45, 630.

[4] Niloff J.M., Knapp R.C., Schaetzl E., Reynolds C., Bast J.M. Jr.: "CA-125 antigen levels in obstetric and gynecologic patients" Obstet. Gynecol., 1984, 64, 703.

[5] Jager W., Diedrich K., Wildt L.: "Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome". Fertil. Steril., 1987, 48 (4), 675.

[6] O'Brien T.J., Beard J.B., Underwood L.J., Shigemasa K.: "The CA-125 gene: a newly discovered extension of the glycosylated Nterminal domain doubles the size of this extracellular superstructure". Tumour Biol., 2002, 23 (3), 154.

[7] Hardardottir H., Parmley T.H. 2"". Quirk J.G. Jr., Sanders M.M., Miller F.C., O'Brien T.J.: "Distribution of CA-125 in embryonic tissues and adult derivatives of the fetal periderm". Am. J. Obstet Gynecol., 1990, 163, 1925.

[8] Davies A., Hart R., Magos A., Hadad E., Morris R.: "Hysterectomy: surgical route and complications". Eur. J. Obstet. Gynecol Reprod. Biol., 2002, 104, 148.

[9] Sills E.S., Saini J., Steiner C.A., McGee M. 3rd, Gretz H.F. 3rd "Abdominal hysterectomy practice patterns in the United States". Int. J. Gynaecol. Obstet., 1998, 63, 277.

[10] Farquhar C.M., Steiner C.A.: "Hysterectomy rates in the United States 1990-1997". Obstet. Gynecol., 2002, 99, 229.

[11] O'Brien T.J., Hardin J.W., Bannon G.A., Norris J.S., Quirk J.G. Jr.: "CA-125 antigen in human amniotic fluid and fetal membranes". Am. J. Obstet. Gynecol., 1986, 155, 50.

[12] Schmidt T., Rein D.T., Foth D., Eibach H.W., Kurbacher C.M., Mallmann P. et al.: "Prognostic value of repeated serum CA-125 measurements in first trimester pregnancy". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 97 (2), 168.

[13] Predanic M.: "Differentiating tubal abortion from viable ectopic pregnancy with serum CA-125 and beta-human chorionic gonadotropin determinations". Fertil Steril., 2000, 73 (3), 522.

[14] T simoyiannis E.C., T simoyiannis J.C., Sarros CJ., Akalestos G.C., Moutesidou K.J., Lekkas E.T. et al.: "The role of oxygenderived free radicals in peritoneal adhesion formation induced by ileal ischaemia/reperfusion". Acta Chir. Scand., 1989, 155, 171.

[15] Kui Wong N., Easton R.L., Panico M., Sutton-Smith M., Morrison J.C., Lattanzio P.A. et al.: "Characterization of the oligosaccharides associated with the human ovarian tumor marker CA-125". J. Biol. Chem., 2003, 278 (31), 28619.

[16] Gaetje R., Winnekendonk D.W., Scharl A., Kaufmann M.: "Ovarian cancer antigen CA-125 enhances the invasiveness of the endometriotic cell line EEC 145". J. Soc. Gynecol. Investig., 1999, 6 (5), 278.